{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_015438.6:c.1039G>A",
          "cDNA Change": {
            "transcript": "NM_015438.6",
            "ref": "G",
            "alt": "A",
            "position": "1039"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "350"
          },
          "Description in input context": "c.1039G>A (p.G350R)"
        },
        {
          "HGVS": "NM_015438.6:c.1074T>C",
          "cDNA Change": {
            "transcript": "NM_015438.6",
            "ref": "T",
            "alt": "C",
            "position": "1074"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "T",
            "position": "360"
          },
          "Description in input context": "c.1074T>C (p.M360T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinsonism",
    "MONDO": "MONDO:0011745"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blotting",
      "Material used": {
        "Material Source": "Cell line/Animal Model",
        "Material Name": "SH-SY5Y cells and primary neurons from wild-type and Lrrk2 knockout mice",
        "Description": "The experiment was conducted using SH-SY5Y neuroblastoma cells and primary neurons derived from wild-type and Lrrk2 knockout mice."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_015438.6:c.1039G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of α-synuclein was observed in cells expressing p.G350R LRRK2."
        },
        {
          "Variant": "NM_015438.6:c.1074T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Cells expressing p.M360T LRRK2 showed increased levels of phosphorylated α-synuclein compared to control cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each experimental condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate during Western blotting."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing cells were used as a positive control to validate the phosphorylation assay."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells and Lrrk2 knockout neurons served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Not applicable, as phosphorylation levels were compared between experimental conditions.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Not applicable, as phosphorylation levels were compared between experimental conditions.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Western blotting is a commonly accepted method for studying protein expression and phosphorylation in the context of Parkinson's disease."
      }
    }
  ]
}